Clinical Trial Update: The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis [Phase 3]

View source ↗

Summary

A confirmatory Phase 3 study of TAU-284 in pediatric patients with perennial allergic rhinitis has completed and posted results. The study was sponsored by Tana…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• TAU-284

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Perennial Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2015-12-15